Your browser doesn't support javascript.
loading
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies.
Thakur, Chitra; Qiu, Yiran; Fu, Yao; Bi, Zhuoyue; Zhang, Wenxuan; Ji, Haoyan; Chen, Fei.
Afiliação
  • Thakur C; Department of Pathology, Stony Brook Cancer Center, Stony Brook, NY, United States.
  • Qiu Y; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, United States.
  • Fu Y; Department of Pathology, Stony Brook Cancer Center, Stony Brook, NY, United States.
  • Bi Z; Department of Pathology, Stony Brook Cancer Center, Stony Brook, NY, United States.
  • Zhang W; Department of Pathology, Stony Brook Cancer Center, Stony Brook, NY, United States.
  • Ji H; Department of Pathology, Stony Brook Cancer Center, Stony Brook, NY, United States.
  • Chen F; Department of Pathology, Stony Brook Cancer Center, Stony Brook, NY, United States.
Front Oncol ; 12: 971288, 2022.
Article em En | MEDLINE | ID: mdl-36185256
ABSTRACT
Breast cancer remains the most frequently diagnosed cancer in women worldwide. Delayed presentation of the disease, late stage at diagnosis, limited therapeutic options, metastasis, and relapse are the major factors contributing to breast cancer mortality. The development and progression of breast cancer is a complex and multi-step process that incorporates an accumulation of several genetic and epigenetic alterations. External environmental factors and internal cellular microenvironmental cues influence the occurrence of these alterations that drives tumorigenesis. Here, we discuss state-of-the-art information on the epigenetics of breast cancer and how environmental risk factors orchestrate major epigenetic events, emphasizing the necessity for a multidisciplinary approach toward a better understanding of the gene-environment interactions implicated in breast cancer. Since epigenetic modifications are reversible and are susceptible to extrinsic and intrinsic stimuli, they offer potential avenues that can be targeted for designing robust breast cancer therapies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article